Document is current
Any future updates will be listed below
-
Authors
Kalaora, Shelly https://orcid.org/0000-0003-1645-4587
Nagler, Adi
Nejman, Deborah
Alon, Michal
Barbolin, Chaya
Barnea, Eilon
Ketelaars, Steven L. C.
Cheng, Kuoyuan
Vervier, Kevin
Shental, Noam
Bussi, Yuval https://orcid.org/0000-0003-0365-431X
Rotkopf, Ron https://orcid.org/0000-0001-9503-7348
Levy, Ronen
Benedek, Gil
Trabish, Sophie
Dadosh, Tali
Levin-Zaidman, Smadar
Geller, Leore T.
Wang, Kun
Greenberg, Polina
Yagel, Gal https://orcid.org/0000-0002-9518-5989
Peri, Aviyah
Fuks, Garold
Bhardwaj, Neerupma
Reuben, Alexandre https://orcid.org/0000-0003-4510-0382
Hermida, Leandro https://orcid.org/0000-0003-3887-518X
Johnson, Sarah B.
Galloway-Peña, Jessica R.
Shropshire, William C.
Bernatchez, Chantale
Haymaker, Cara https://orcid.org/0000-0002-1317-9287
Arora, Reetakshi
Roitman, Lior
Eilam, Raya
Weinberger, Adina
Lotan-Pompan, Maya
Lotem, Michal
Admon, Arie https://orcid.org/0000-0003-0504-3950
Levin, Yishai
Lawley, Trevor D. https://orcid.org/0000-0002-4805-621X
Adams, David J. https://orcid.org/0000-0001-9490-0306
Levesque, Mitchell P.
Besser, Michal J.
Schachter, Jacob
Golani, Ofra https://orcid.org/0000-0002-9793-236X
Segal, Eran https://orcid.org/0000-0002-6859-1164
Geva-Zatorsky, Naama https://orcid.org/0000-0002-7303-854X
Ruppin, Eytan https://orcid.org/0000-0002-7862-3940
Kvistborg, Pia https://orcid.org/0000-0002-4988-608X
Peterson, Scott N.
Wargo, Jennifer A. https://orcid.org/0000-0003-3438-7576
Straussman, Ravid https://orcid.org/0000-0002-9476-329X
Samuels, Yardena https://orcid.org/0000-0002-3349-7266
- License Information
-
More Information
Article History
Received: 4 November 2019
Accepted: 17 February 2021
First Online: 17 March 2021
Competing interests
: J.A.W. is an inventor on a US patent application (PCT/US17/53.717) submitted by the University of Texas MD Anderson Cancer Center that covers methods to enhance immune checkpoint blockade responses by modulating the microbiome. J.A.W. reports compensation for speaker’s bureau and honoraria from Imedex, Dava Oncology, Omniprex, Illumina, Gilead, PeerView, Physician Education Resource, MedImmune and Bristol–Myers Squibb. J.A.W. serves as a consultant/advisory board member for Roche/Genentech, Novartis, AstraZeneca, GlaxoSmithKline, Bristol–Myers Squibb, Merck, Biothera Pharmaceuticals and Microbiome DX. J.A.W. also receives research support from GlaxoSmithKline, Roche/Genentech, Bristol–Myers Squibb and Novartis.
